Estimated delivery in United States, on Tuesday 10 Dec 2024
Product Information
Name:
Epigallocatechin
Synonyms:
- Epigallocatechol
- Antiscurvy factor C2
- Teacatechin II
- (-)-3,3′,4′,5,5′,7-Flavanhexol
- (-)-Epigallocatechol
- (-)-epi-Gallocatechin
- (2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3,5,7-trihydroxychroman
- (2R,3R)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol
- (2R,3R)-3,4-Dihydro-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3,5,7-triol
- 1-epi-3′,4′,5′,5,7-Pentahydroxy-3-flavanol
- See more synonyms
- 2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol
- 2H-1-Benzopyran-3,5,7-triol, 3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-, (2R,3R)-
- 2H-1-Benzopyran-3,5,7-triol, 3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-, (2R-cis)-
- <span class="text-smallcaps">L</span>-Epigallocatechin
- Antiscurvy factor C<sub>2</sub>
- EGC
- Factor C<sub>2</sub> (antiscurvy)
- Gallocatechol, l-
- Galloepicatechin
- NSC 674039
- Sunphenon EGC
- l-Epigallocatechin
- l-Epigallocatechol
Description:
(-)-Epigallocatechin (EGC) can suppress oxidation of plasma low density lipoprotein (LDL) in vitro.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biopurify
Long term storage:
Notes:
Chemical properties
Molecular weight:
306.27
Formula:
C15H14O7
Purity:
95%~99%
Color/Form:
Powder
InChI:
InChI=1S/C15H14O7/c16-7-3-9(17)8-5-12(20)15(22-13(8)4-7)6-1-10(18)14(21)11(19)2-6/h1-4,12,15-21H,5H2/t12-,15-/m1/s1
InChI key:
InChIKey=XMOCLSLCDHWDHP-IUODEOHRSA-N
SMILES:
Oc1cc(O)c2c(c1)O[C@H](c1cc(O)c(O)c(O)c1)[C@H](O)C2
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: BP-BP0541 Epigallocatechin
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
